Technological innovations have fundamentally changed diabetes care. Insulin pump use and continuous glucose monitoring are associated with improved glycemic control along with a better quality of life; automated insulin-dosing advisors facilitate and improve decision making. Glucose-responsive automated insulin delivery enables the highest targets for time in range, lowest rate and duration of hypoglycemia, and favorable quality of life. Clear targets for time in ranges and a standard visualization of the data will help the diabetes technology to be used more efficiently. Decision support systems within and integrated cloud environment will further simplify, unify, and improve modern routine diabetes care.
Keywords: Artificial pancreas; Closed loop; Continuous glucose monitoring; Insulin pump; Multiple daily injections; Self-monitoring of blood glucose; Technology; Type 1 diabetes.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.